39 related articles for article (PubMed ID: 18294707)
1. Transformation and Tumorigenicity Testing of Simian Cell Lines and Evaluation of Poliovirus Replication.
Dotti S; Lombardo T; Villa R; Cacciamali A; Zanotti C; Andreani NA; Cinotti S; Ferrari M
PLoS One; 2017; 12(1):e0169391. PubMed ID: 28046048
[TBL] [Abstract][Full Text] [Related]
2. Fexaramine as an entry blocker for feline caliciviruses.
Kim Y; Chang KO
Antiviral Res; 2018 Apr; 152():76-83. PubMed ID: 29454892
[TBL] [Abstract][Full Text] [Related]
3. Poliovirus infection without accumulation of eclipse particles.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
[TBL] [Abstract][Full Text] [Related]
4. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
[TBL] [Abstract][Full Text] [Related]
5. Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile.
Garozzo A; Stivala A; Tempera G; Castro A
Antiviral Res; 2010 Dec; 88(3):325-8. PubMed ID: 20955736
[TBL] [Abstract][Full Text] [Related]
6. Potential use of antiviral agents in polio eradication.
De Palma AM; Pürstinger G; Wimmer E; Patick AK; Andries K; Rombaut B; De Clercq E; Neyts J
Emerg Infect Dis; 2008 Apr; 14(4):545-51. PubMed ID: 18394270
[TBL] [Abstract][Full Text] [Related]
7. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
[TBL] [Abstract][Full Text] [Related]
8. A case for developing antiviral drugs against polio.
Collett MS; Neyts J; Modlin JF
Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
[TBL] [Abstract][Full Text] [Related]
9. One hundred years of poliovirus pathogenesis.
Racaniello VR
Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
[TBL] [Abstract][Full Text] [Related]
10. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
McKinlay MA; Collett MS; Hincks JR; Oberste MS; Pallansch MA; Okayasu H; Sutter RW; Modlin JF; Dowdle WR
J Infect Dis; 2014 Nov; 210 Suppl 1():S447-53. PubMed ID: 25316866
[TBL] [Abstract][Full Text] [Related]
11. Some problems of molecular biology of poliovirus infection relevant to pathogenesis, viral spread and evolution.
Agol VI; Belov GA; Cherkasova EA; Gavrilin GV; Kolesnikova MS; Romanova LI; Tolskaya EA
Dev Biol (Basel); 2001; 105():43-50. PubMed ID: 11763336
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
